Skip to main content
Premium Trial:

Request an Annual Quote

NIJ Awards $800K Grant to Assess NGS Technology for Forensics

NEW YORK (GenomeWeb) – The National Institute of Justice has awarded a team of researchers $825,000 to assess the use of next-generation sequencing technology for forensic applications, Pennsylvania State University said on Thursday. 

Battelle Memorial Institute, the lead institute on the grant, will work with Penn State and six other federal and local laboratories to test the feasibility of new instruments, laboratory materials, and software tools for DNA-based forensics science with the goal of vetting NGS technologies and implementing them into working crime laboratories. 

Penn State is the only university partner on the grant, it said, and it will run evaluations of forensic investigative tools that could expand the capabilities of forensic DNA labs. 

According to the grant abstract, DNA samples provided by the National Institute of Standards and Technology will be sequenced using Illumina's MiSeq platform or Life Technologies' Ion PGM Sequencing System. Interlaboratory testing will be managed by Battelle; Penn State; NIST; the Armed Forces DNA Identification Laboratory; the Bureau of Alcohol, Tobacco, Firearms, and Explosives; the California Department of Justice; the Philadelphia Police Department; and the Harris County Institute of Forensic Sciences.

"This exciting technology allows for the generation of DNA profiles that can be compared to known suspects, victims, or profiles within state and federal databases while also exploiting new locations on the DNA where single base-pair differences may provide 'investigative information' in cases where no suspects have been developed or discovered,"Penn State professor Jenifer Smith said in a statement. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.